- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-39-0008739

Stedel Pharmaceuticals Private Limited
About Stedel Pharmaceuticals Private Limited
Data last updated:
Stedel Pharmaceuticals Private Limited is a private limited company based in Jhansi, Uttar Pradesh, India. It operates in the retail trade segment of the trading and commerce sector. It was incorporated on 08 January 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U21000UP2010PTC039204. Its GSTIN is 09AANCS9059H1ZM (Uttar Pradesh).
The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Arvind Kumar Dubey (Managing Director) and Chandra Prabha Dubey.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1496 Nai Basti, Jhansi, Uttar Pradesh, India – 284002.
As per the financials filed for FY 2025, the company reported a revenue of ₹22.24 Lakh, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹9,641 (net margin 0.4%) and EBITDA of ₹38,043 (EBITDA margin 1.7%). Revenue has declined at a compounded annual rate (CAGR) of 4% over three years and 10% over five years.
Stedel Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-39-0008739). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Stedel Pharmaceuticals has one previous CIN (Corporate Identification Number): U74900UP2010PTC039204. The current CIN is U21000UP2010PTC039204, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U21000UP2010PTC039204 | Current |
| U74900UP2010PTC039204 | Previous |
Recognitions & Rankings of Stedel Pharmaceuticals
Contact details
Stedel Pharmaceuticals Private Limited's registered office is in Jhansi, Uttar Pradesh.
- Registered Address1496 Nai Basti, Jhansi, Uttar Pradesh, India – 284002
- IndustryTrading, Retailers, Retail Trading
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Stedel Pharmaceuticals is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Stedel Pharmaceuticals Private Limited, buy the company report.
Financials of Stedel Pharmaceuticals Private Limited
FY 2025 filings availableStedel Pharmaceuticals Private Limited reported revenue of ₹22.24 Lakh (down 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 10% over five years, including a 2% fall in the latest year. EBITDA fell 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹38,043 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9,641 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.7% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Stedel Pharmaceuticals Private Limited, buy the company report.
Board of directors of Stedel Pharmaceuticals Private Limited
Stedel Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arvind Kumar Dubey | Managing Director | 08 Jan 2010 | 16 Years 9 Months | Current |
| Chandra Prabha Dubey | Director | 08 Jan 2010 | 16 Years 9 Months | Current |
Legal cases
No court or tribunal cases involving Stedel Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Stedel Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Stedel Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AANCS9059H1ZM | Uttar Pradesh | Active | 31 Aug 2017 |
To see the full GST registrations and return filing status of Stedel Pharmaceuticals Private Limited, buy the company report.
Recent activity
Stedel Pharmaceuticals Private Limited has 4 board changes on record since 2010: 2 appointments and 2 cessations. The latest: Alok Gupta ceased to be Director on 30 Nov 2011.
Frequently asked questions
Stedel Pharmaceuticals is an active private limited company based in Jhansi, Uttar Pradesh, India. The company works in retailers, within the trading industry. It was incorporated on 08 January 2010 (16+ years old) and is registered under CIN U21000UP2010PTC039204.
Stedel Pharmaceuticals has 2 current directors:
- Arvind Kumar Dubey - Managing Director
- Chandra Prabha Dubey - Director
The latest financial statements of Stedel Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Stedel Pharmaceuticals is 09AANCS9059H1ZM, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Stedel Pharmaceuticals is U21000UP2010PTC039204. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stedel Pharmaceuticals was incorporated on 08 January 2010, making it 16+ years old. It is registered with the Registrar of Companies, Kanpur.
Alok Gupta ceased to be Director on 30 Nov 2011. Anita Seth ceased to be Director on 30 Nov 2011. Arvind Kumar Dubey was appointed as Managing Director on 08 Jan 2010. Stedel Pharmaceuticals has 4 board changes on record in total.
Yes, Stedel Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-39-0008739).
The registered office of Stedel Pharmaceuticals is at 1496 Nai Basti, Jhansi, Uttar Pradesh, India – 284002.
Stedel Pharmaceuticals operates in the trading industry, in the retailers segment.

